Fairmount Funds Management LLC
Top Portfolio Positions
12 positions ·
$1,457,080,670 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
8,713,000 | $225,666,700 | 15.49% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
2,537,191 | $212,921,068 | 14.61% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
5,503,418 | $211,826,558 | 14.54% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
4,018,101 | $202,673,014 | 13.91% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
3,705,262 | $181,743,101 | 12.47% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
3,711,288 | $145,482,488 | 9.98% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
3,914,458 | $76,566,798 | 5.25% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
4,553,494 | $63,976,590 | 4.39% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
2,747,866 | $50,478,298 | 3.46% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
2,359,025 | $46,118,938 | 3.17% |
Portfolio Trend
25 quarters · across all stocks
Holdings in NUVL
Shares Held
Position Value (USD)
18 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $73,185,562 | 727,563 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $62,919,648 | 727,563 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $55,513,056 | 727,563 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $51,598,767 | 727,563 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $103,146,737 | 1,317,664 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $172,586,647 | 1,687,064 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $146,002,128 | 1,924,626 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $144,520,166 | 1,924,626 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $141,633,227 | 1,924,626 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $112,710,119 | 2,451,819 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $121,639,027 | 2,884,492 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $75,256,396 | 2,884,492 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $83,055,854 | 2,788,981 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $40,432,536 | 2,079,863 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $23,262,424 | 1,715,518 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $18,590,278 | 1,338,393 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,414,250 | 914,614 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,624,545 | 914,614 | Shares | Sole | 2021-11-15 | |
| No 13F history on record for this holder in this stock. | ||||||